Global Cytology and HPV Testing Competitive Landscape Professional Research Report 2026

According to DIResearch＇s in-depth investigation and research, the global Cytology and HPV Testing market size will reach 5,340.12 Million USD in 2025 and is projected to reach 8,993.06 Million USD by 2032, with a CAGR of 7.73% (2025-2032). Notably, the China Cytology and HPV Testing market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.

Research Summary

Cytology and HPV testing are two methods used in cervical cancer screening to detect abnormalities in cervical cells and identify the presence of human papillomavirus (HPV), a common sexually transmitted infection known to cause cervical cancer. Cytology, also known as the Pap test or Pap smear, involves collecting cells from the cervix and examining them under a microscope to identify any abnormal changes, such as precancerous or cancerous cells. HPV testing, on the other hand, detects the presence of high-risk HPV strains in cervical cells, which are associated with an increased risk of cervical cancer. The combination of cytology and HPV testing allows for more accurate and comprehensive screening, as it can detect both cellular abnormalities and the presence of HPV infection. This dual approach has greatly improved the effectiveness of cervical cancer screening programs, enabling early detection and treatment of precancerous lesions, ultimately reducing the incidence and mortality of cervical cancer.

The major global suppliers of Cytology and HPV Testing include Thermo Fisher Scientific, Roche Diagnostics, QIAGEN, Bio-rad, Hologic, BD, Hybribio, KingMed Diagnostics, Abbott, bioMérieux, Cepheid, BGI Group, Seegene, Daan Gene, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Cytology and HPV Testing. Focus on analysing the market share, product portfolio, prices, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Cytology and HPV Testing market. The report data covers historical data from 2021 to 2025, based year in 2026 and forecast data from 2027 to 2033.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Cytology and HPV Testing market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Cytology and HPV Testing industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.  

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Suppliers of Cytology and HPV Testing Include:

Thermo Fisher Scientific

Roche Diagnostics

QIAGEN

Bio-rad

Hologic

BD

Hybribio

KingMed Diagnostics

Abbott

bioMérieux

Cepheid

BGI Group

Seegene

Daan Gene

Cytology and HPV Testing Product Segment Include:

Instruments

Consumables

Services

Cytology and HPV Testing Product Application Include:

Hospitals & Clinics

Laboratories

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Cytology and HPV Testing Industry PESTEL Analysis

Chapter 3: Global Cytology and HPV Testing Industry Porter’s Five Forces Analysis

Chapter 4: Global Cytology and HPV Testing Major Regional Market Size and Forecast Analysis

Chapter 5: Global Cytology and HPV Testing Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Passenger Cytology and HPV Testing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Cytology and HPV Testing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Cytology and HPV Testing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Cytology and HPV Testing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Cytology and HPV Testing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Cytology and HPV Testing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Cytology and HPV Testing Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table 1： Global Cytology and HPV Testing Market Size Growth Rate by Type, 2025 VS 2026 VS 2033 (US$ Million)

Table 2： Global Cytology and HPV Testing Market Size Growth Rate by Application, 2025 VS 2026 VS 2033 (US$ Million)

Table 3： Cytology and HPV Testing Industry Development Status

Table 4： Cytology and HPV Testing Industry Development Trends

Table 5： Global Cytology and HPV Testing Market Size by Region in US$ Million: 2025 VS 2026 VS 2033

Table 6： Global Cytology and HPV Testing Revenue by Region (2021-2026) & (US$ Million)

Table 7： Global Cytology and HPV Testing Revenue Market Share by Region (2021-2026)

Table 8： Global Cytology and HPV Testing Revenue Forecast by Region (2027-2033) & (US$ Million)

Table 9： Global Cytology and HPV Testing Revenue Market Share Forecast by Region (2027-2033)

Table 10： Global Cytology and HPV Testing Revenue Analysis by Type (2021-2026) & (US$ Million)

Table 11： Global Cytology and HPV Testing Revenue Analysis Forecast by Type (2027-2033) & (US$ Million)

Table 12： Global Cytology and HPV Testing Revenue Analysis by Application (2021-2026) & (US$ Million)

Table 13： Global Cytology and HPV Testing Revenue Analysis Forecast by Application (2027-2033) & (US$ Million)

Table 14： Key Cytology and HPV Testing Players in North America

Table 15： North America Cytology and HPV Testing Revenue by Type (2021-2026) & (US$ Million)

Table 16： North America Cytology and HPV Testing Revenue by Type (2027-2033) & (US$ Million)

Table 17： North America Cytology and HPV Testing Revenue by Application (2021-2026) & (US$ Million)

Table 18： North America Cytology and HPV Testing Revenue by Application (2027-2033) & (US$ Million)

Table 19： North America Cytology and HPV Testing Revenue Market Size by Country (2021-2026) & (US$ Million)

Table 20： North America Cytology and HPV Testing Revenue Market Size by Country (2027-2033) & (US$ Million)

Table 21： Key Cytology and HPV Testing Players in Europe

Table 22： Europe Cytology and HPV Testing Revenue by Type (2021-2026) & (US$ Million)

Table 23： Europe Cytology and HPV Testing Revenue by Type (2027-2033) & (US$ Million)

Table 24： Europe Cytology and HPV Testing Revenue by Application (2021-2026) & (US$ Million)

Table 25： Europe Cytology and HPV Testing Revenue by Application (2027-2033) & (US$ Million)

Table 26： Europe Cytology and HPV Testing Revenue Market Size by Country (2021-2026) & (US$ Million)

Table 27： Europe Cytology and HPV Testing Revenue Market Size by Country (2027-2033) & (US$ Million)

Table 28： Key Cytology and HPV Testing Players in China

Table 29： China Cytology and HPV Testing Revenue by Type (2021-2026) & (US$ Million)

Table 30： China Cytology and HPV Testing Revenue by Type (2027-2033) & (US$ Million)

Table 31： China Cytology and HPV Testing Revenue by Application (2021-2026) & (US$ Million)

Table 32： China Cytology and HPV Testing Revenue by Application (2027-2033) & (US$ Million)

Table 33： Key Cytology and HPV Testing Players in APAC (excl. China)

Table 34： APAC (excl. China) Cytology and HPV Testing Revenue by Type (2021-2026) & (US$ Million)

Table 35： APAC (excl. China) Cytology and HPV Testing Revenue by Type (2027-2033) & (US$ Million)

Table 36： APAC (excl. China) Cytology and HPV Testing Revenue by Application (2021-2026) & (US$ Million)

Table 37： APAC (excl. China) Cytology and HPV Testing Revenue by Application (2027-2033) & (US$ Million)

Table 38： APAC (excl. China) Cytology and HPV Testing Revenue Market Size by Country (2021-2026) & (US$ Million)

Table 39： APAC (excl. China) Cytology and HPV Testing Revenue Market Size by Country (2027-2033) & (US$ Million)

Table 40： Key Cytology and HPV Testing Players in Latin America

Table 41： Latin America Cytology and HPV Testing Revenue by Type (2021-2026) & (US$ Million)

Table 42： Latin America Cytology and HPV Testing Revenue by Type (2027-2033) & (US$ Million)

Table 43： Latin America Cytology and HPV Testing Revenue by Application (2021-2026) & (US$ Million)

Table 44： Latin America Cytology and HPV Testing Revenue by Application (2027-2033) & (US$ Million)

Table 45： Latin America Cytology and HPV Testing Revenue Market Size by Country (2021-2026) & (US$ Million)

Table 46： Latin America Cytology and HPV Testing Revenue Market Size by Country (2027-2033) & (US$ Million)

Table 47： Key Cytology and HPV Testing Players in Middle East & Africa

Table 48： Middle East & Africa Cytology and HPV Testing Revenue by Type (2021-2026) & (US$ Million)

Table 49： Middle East & Africa Cytology and HPV Testing Revenue by Type (2027-2033) & (US$ Million)

Table 50： Middle East & Africa Cytology and HPV Testing Revenue by Application (2021-2026) & (US$ Million)

Table 51： Middle East & Africa Cytology and HPV Testing Revenue by Application (2027-2033) & (US$ Million)

Table 52： Middle East & Africa Cytology and HPV Testing Revenue Market Size by Country (2021-2026) & (US$ Million)

Table 53： Middle East & Africa Cytology and HPV Testing Revenue Market Size by Country (2027-2033) & (US$ Million)

Table 54： Global Cytology and HPV Testing Market Revenue by Key Suppliers (2021-2026) & (US$ Million)

Table 55： Global Cytology and HPV Testing Revenue Market Share by Key Suppliers (2021-2026)

Table 56： Global Key Suppliers Headquarter Location and Key Area Sales

Table 57： Market Mergers & Acquisitions, Expansion

Table 58： Thermo Fisher Scientific Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 59： Thermo Fisher Scientific Cytology and HPV Testing Product Portfolio

Table 60： Thermo Fisher Scientific Cytology and HPV Testing Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 61： Roche Diagnostics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 62： Roche Diagnostics Cytology and HPV Testing Product Portfolio

Table 63： Roche Diagnostics Cytology and HPV Testing Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 64： QIAGEN Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 65： QIAGEN Cytology and HPV Testing Product Portfolio

Table 66： QIAGEN Cytology and HPV Testing Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 67： Bio-rad Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 68： Bio-rad Cytology and HPV Testing Product Portfolio

Table 69： Bio-rad Cytology and HPV Testing Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 70： Hologic Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 71： Hologic Cytology and HPV Testing Product Portfolio

Table 72： Hologic Cytology and HPV Testing Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 73： BD Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 74： BD Cytology and HPV Testing Product Portfolio

Table 75： BD Cytology and HPV Testing Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 76： Hybribio Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 77： Hybribio Cytology and HPV Testing Product Portfolio

Table 78： Hybribio Cytology and HPV Testing Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 79： KingMed Diagnostics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 80： KingMed Diagnostics Cytology and HPV Testing Product Portfolio

Table 81： KingMed Diagnostics Cytology and HPV Testing Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 82： Abbott Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 83： Abbott Cytology and HPV Testing Product Portfolio

Table 84： Abbott Cytology and HPV Testing Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 85： bioMérieux Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 86： bioMérieux Cytology and HPV Testing Product Portfolio

Table 87： bioMérieux Cytology and HPV Testing Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 88： Cepheid Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 89： Cepheid Cytology and HPV Testing Product Portfolio

Table 90： Cepheid Cytology and HPV Testing Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 91： BGI Group Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 92： BGI Group Cytology and HPV Testing Product Portfolio

Table 93： BGI Group Cytology and HPV Testing Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 94： Seegene Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 95： Seegene Cytology and HPV Testing Product Portfolio

Table 96： Seegene Cytology and HPV Testing Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 97： Daan Gene Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 98： Daan Gene Cytology and HPV Testing Product Portfolio

Table 99： Daan Gene Cytology and HPV Testing Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 100： Cytology and HPV Testing Typical Customer List

Table 101： Cytology and HPV Testing Distributors List

Figure 1： Cytology and HPV Testing Product Pictures

Figure 2： Instruments Picture Scope

Figure 3： Consumables Picture Scope

Figure 4： Services Picture Scope

Figure 5： Hospitals & Clinics Picture Scope

Figure 6： Laboratories Picture Scope

Figure 7： Others Picture Scope

Figure 8： Global Cytology and HPV Testing Market Size Analysis: 2025 VS 2026 VS 2033 (US$ Million)

Figure 9： Global Cytology and HPV Testing Market Revenue and Growth Rate Analysis: (2021-2033) & (US$ Million)

Figure 10： Global Cytology and HPV Testing Market Size by Region (2021-2033) & (US$ Million)

Figure 11： Global Cytology and HPV Testing Market Share Scenario by Region in Percentage: 2026 Versus 2033

Figure 12： North America Cytology and HPV Testing Market Size and Growth Rate (2021-2033) & (US$ Million)

Figure 13： North America Cytology and HPV Testing Market Share by Players in 2025

Figure 14： North America Cytology and HPV Testing Revenue Market Share by Type (2021-2033)

Figure 15： North America Cytology and HPV Testing Revenue Market Share by Application (2021-2033)

Figure 16： US Cytology and HPV Testing Revenue (2021-2033) & (US$ Million)

Figure 17： Canada Cytology and HPV Testing Revenue (2021-2033) & (US$ Million)

Figure 18： Europe Cytology and HPV Testing Market Size and Growth Rate (2021-2033) & (US$ Million)

Figure 19： Europe Cytology and HPV Testing Market Share by Players in 2025

Figure 20： Europe Cytology and HPV Testing Revenue Market Share by Type (2021-2033)

Figure 21： Europe Cytology and HPV Testing Revenue Market Share by Application (2021-2033)

Figure 22： Germany Cytology and HPV Testing Revenue (2021-2033) & (US$ Million)

Figure 23： France Cytology and HPV Testing Revenue (2021-2033) & (US$ Million)

Figure 24： United Kingdom Cytology and HPV Testing Revenue (2021-2033) & (US$ Million)

Figure 25： Italy Cytology and HPV Testing Revenue (2021-2033) & (US$ Million)

Figure 26： Spain Cytology and HPV Testing Revenue (2021-2033) & (US$ Million)

Figure 27： Benelux Cytology and HPV Testing Revenue (2021-2033) & (US$ Million)

Figure 28： China Cytology and HPV Testing Market Size and Growth Rate (2021-2033) & (US$ Million)

Figure 29： China Cytology and HPV Testing Market Share by Players in 2025

Figure 30： China Cytology and HPV Testing Revenue Market Share by Type (2021-2033)

Figure 31： China Cytology and HPV Testing Revenue Market Share by Application (2021-2033)

Figure 32： APAC (excl. China) Cytology and HPV Testing Market Size and Growth Rate (2021-2033) & (US$ Million)

Figure 33： APAC (excl. China) Cytology and HPV Testing Market Share by Players in 2025

Figure 34： APAC (excl. China) Cytology and HPV Testing Revenue Market Share by Type (2021-2033)

Figure 35： APAC (excl. China) Cytology and HPV Testing Revenue Market Share by Application (2021-2033)

Figure 36： Japan Cytology and HPV Testing Revenue (2021-2033) & (US$ Million)

Figure 37： South Korea Cytology and HPV Testing Revenue (2021-2033) & (US$ Million)

Figure 38： India Cytology and HPV Testing Revenue (2021-2033) & (US$ Million)

Figure 39： Australia Cytology and HPV Testing Revenue (2021-2033) & (US$ Million)

Figure 40： Southeast Asia Cytology and HPV Testing Revenue (2021-2033) & (US$ Million)

Figure 41： Latin America Cytology and HPV Testing Market Size and Growth Rate (2021-2033) & (US$ Million)

Figure 42： Latin America Cytology and HPV Testing Market Share by Players in 2025

Figure 43： Latin America Cytology and HPV Testing Revenue Market Share by Type (2021-2033)

Figure 44： Latin America Cytology and HPV Testing Revenue Market Share by Application (2021-2033)

Figure 45： Mexico Cytology and HPV Testing Revenue (2021-2033) & (US$ Million)

Figure 46： Brazil Cytology and HPV Testing Revenue (2021-2033) & (US$ Million)

Figure 47： Middle East & Africa Cytology and HPV Testing Market Size and Growth Rate (2021-2033) & (US$ Million)

Figure 48： Middle East & Africa Cytology and HPV Testing Market Share by Players in 2025

Figure 49： Middle East & Africa Cytology and HPV Testing Revenue Market Share by Type (2021-2033)

Figure 50： Middle East & Africa Cytology and HPV Testing Revenue Market Share by Application (2021-2033)

Figure 51： Saudi Arabia Cytology and HPV Testing Revenue (2021-2033) & (US$ Million)

Figure 52： South Africa Cytology and HPV Testing Revenue (2021-2033) & (US$ Million)

Figure 53： Global Cytology and HPV Testing Revenue Market Share by Key Suppliers in 2025

Figure 54： Global Cytology and HPV Testing Industry Competition Landscape

Figure 55： Cytology and HPV Testing Industry Chain Analysis

Figure 56： Bottom-Up and Top-Down Research Methods

Figure 57： Key Interview Objectives

Figure 58： Data Cross Validation